Evidence map›Paper›PMID 31730381›Full record

ReviewAnnual review of physiology2020

Aging and Lung Disease.

Soo Jung Cho, Heather W Stout-Delgado

Open access · bronzeAbstract readReview
In one paragraph

Review in Annual review of physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 286 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
286citing papers in PubMed, 6 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

286 citing papers in PubMed, 6 syntheses or guidelines pooled it, 448 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. mExperimental and therapeutic medicine · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

226 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Soo Jung ChoDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA; email: hes2019@med.cornell.edu.
Heather W Stout-DelgadoDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA; email: hes2019@med.cornell.edu.
Weill Cornell Medicine · US

Funding

Impact of Heightened UPR Activation on Inflammasome Responses to Influenza and Secondary Streptococcus pneumoniae Infection in Aged LungR01AG056699 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI STOUT DELGADO, HEATHER WINONA · 2018 to 2022
$2.6M
Impact of Heightened ER Stress on NLRP3 Activation in Aged Lung during InfectionR01AG052530 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI STOUT DELGADO, HEATHER WINONA · 2017 to 2021
$2.1M
GLUT1-dependent glycolysis regulates age-susceptible lung fibrosisK08HL138285 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHO, SOO JUNG · 2017 to 2021
$829k
NHLBI NIH HHS K08 HL138285NIA NIH HHS R01 AG052530NIA NIH HHS R01 AG056699
6 · The paper itself

Abstract

People worldwide are living longer, and it is estimated that by 2050, the proportion of the world's population over 60 years of age will nearly double. Natural lung aging is associated with molecular and physiological changes that cause alterations in lung function, diminished pulmonary remodeling and regenerative capacity, and increased susceptibility to acute and chronic lung diseases. As the aging population rapidly grows, it is essential to examine how alterations in cellular function and cell-to-cell interactions of pulmonary resident cells and systemic immune cells contribute to a higher risk of increased susceptibility to infection and development of chronic diseases, such as chronic obstructive pulmonary disease and interstitial pulmonary fibrosis. This review provides an overview of physiological, structural, and cellular changes in the aging lung and immune system that facilitate the development and progression of disease.

Indexed as

AgedAgingCellular SenescenceHumansLungLung DiseasesMiddle Agedacute respiratory distress syndromeARDSchronic obstructive pulmonary diseaseCOPDinflammationinterstitial pulmonary fibrosisIPFlung agingpneumonia

Identifiers

PMID31730381
PMCPMC7998901
OpenAlexW2984453596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.